Article Text
Abstract
Background Medical schools are grappling with how best to manage industry involvement in medical education.
Objective To describe a case study of industry-supported undergraduate medical education related to opioid analgesics.
Method Institutional case study.
Results As part of their regular curriculum, Canadian medical students attended pain pharmacotherapy lectures that contained questionable content about the use of opioids for pain management. The lectures were supported by pharmaceutical companies that market opioid analgesics in Canada and the guest lecturer was a member of speakers bureaus of the same companies. These conflicts of interests were not fully disclosed. A reference book that reinforced some of the information in the lectures and that was paid for by a sponsoring company was made available to students. This is the first report of an association between industry sponsorship and the dissemination of potentially dangerous information to medical students.
Conclusions This case demonstrates the need for better strategies for preventing, identifying and dealing with problematic interactions between the pharmaceutical industry and undergraduate medical education. These might include the avoidance of unnecessary conflicts of interest, more disclosure of conflicts, an open process for dealing with recognised problems and internationally harmonised conflict of interest policies.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Statistics from Altmetric.com
Other content recommended for you
- Evidence for stratified conflicts of interest policies in research contexts: a methodological review
- Role of active patient involvement in undergraduate medical education: a systematic review
- Recent advances in opioid prescription for chronic non-cancer pain
- Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): the protocol of an exploratory, randomised controlled trial
- Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies
- Industry-funded medical education is always promotion—an essay by Adriane Fugh-Berman
- Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
- Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
- The opioid epidemic: helping rheumatologists prevent a crisis
- General practitioners’ attitudes towards opioids for non-cancer pain: a qualitative systematic review